Literature DB >> 3171464

Quantitative in-situ hybridization histochemistry in the rat pituitary gland: effect of bromocriptine on prolactin and pro-opiomelanocortin gene expression.

A Levy1, S L Lightman.   

Abstract

The temporal effect of orally administered bromocriptine on pro-opiomelanocortin (POMC) and prolactin gene expression in male Sprague-Dawley rats was examined using in-situ hybridization histochemistry. Messenger RNA in the anterior and intermediate lobes could be clearly delineated in each section. Administration of bromocriptine resulted in a reduction in hybridization of 35S-labelled cDNA probe to prolactin mRNA from 0.69 x 10(12) to 0.29 x 10(12) copies bound/g after 150 h. POMC mRNA in the anterior lobe remained unchanged with 0.08 x 10(12) copies of probe bound/g for the duration of the experiment, while in the intermediate lobe it decreased from 2.44 x 10(12) to 0.44 x 10(12) copies of probe bound/g at 150 h. The rate of reduction in intermediate lobe POMC mRNA was similar to that of prolactin mRNA for the first 24 h but was subsequently more rapid and more profound, falling to 20% of the control value at 84 h and to 18% at 150 h.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3171464     DOI: 10.1677/joe.0.1180205

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  3 in total

1.  Bromocriptine reduces rat thyrotropin beta-subunit mRNA stability.

Authors:  A Levy; S L Lightman
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

2.  Vasopressin RNA in the neural lobe of the pituitary: dramatic accumulation in response to salt loading.

Authors:  D Murphy; A Levy; S Lightman; D Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  GFAP expression induced by dopamine D(2) receptor agonists in the rat pituitary intermediate lobe.

Authors:  S A Sands; B M Chronwall
Journal:  Endocrine       Date:  1996-02       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.